RXO
RXO, Inc.
Trucking
Market Cap$3.23B
5Y Perf.-6.6%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
RXO vs CHRW
Revenue, margins, valuation, and 5-year total return — side by side.
CHRW
C.H. Robinson Worldwide, Inc.
Integrated Freight & Logistics
Market Cap$20.00B
5Y Perf.+72.5%
RXO vs CHRW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | RXO | CHRW |
|---|---|---|
| Industry | Trucking | Integrated Freight & Logistics |
| Market Cap | $3.23B | $20.00B |
| Revenue (TTM) | $5.74B | $16.20B |
| Net Income (TTM) | $-100M | $599M |
| Gross Margin | 17.2% | 8.3% |
| Operating Margin | -0.6% | 4.9% |
| Forward P/E | — | 27.4x |
| Total Debt | $861M | $1.63B |
| Cash & Equiv. | $18M | $161M |
RXO vs CHRW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
RXO
CHRW
| Stock | Oct 22 | May 26 | Return |
|---|---|---|---|
| RXO, Inc. (RXO) | 100 | 93.4 | -6.6% |
| C.H. Robinson World… (CHRW) | 100 | 172.5 | +72.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RXO vs CHRW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: CHRW leads in 5 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. RXO, Inc. is the stronger pick specifically for growth and revenue expansion. As sector peers, any of these can serve as alternatives in the same allocation.
RXO
RXO, Inc.
The Growth Play
RXO is the clearest fit if your priority is growth exposure.
- Rev growth 26.2%, EPS growth 72.8%, 3Y rev CAGR 6.2%
- 26.2% revenue growth vs CHRW's -8.4%
Best for: growth exposure
CHRW
C.H. Robinson Worldwide, Inc.
The Income Pick
CHRW carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.95, yield 1.5%
- 160.9% 10Y total return vs RXO's -6.6%
- Lower volatility, beta 0.95, Low D/E 88.3%, current ratio 1.53x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | RXO | 26.2% revenue growth vs CHRW's -8.4% |
| Quality / Margins | CHRW | 3.7% margin vs RXO's -1.7% |
| Stability / Safety | CHRW | Beta 0.95 vs RXO's 2.74 |
| Dividends | CHRW | 1.5% yield; 5-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | CHRW | +93.7% vs RXO's +42.6% |
| Efficiency (ROA) | CHRW | 11.5% ROA vs RXO's -3.1%, ROIC 18.0% vs -0.2% |
RXO vs CHRW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
RXO vs CHRW — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCHRWLAGGINGRXO
RXORXO, Inc.
1leads
CHRWC.H. Robinson Worldwi…
3leads
6 Total Categories
CATEGORYLEADERvs RXOMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
CHRW5/6
Valuation MetricsMultiples, price ratios, and targets
RXO3/4
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
CHRW6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
CHRW5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
CHRW leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CHRW is the larger business by revenue, generating $16.2B annually — 2.8x RXO's $5.7B. CHRW is the more profitable business, keeping 3.7% of every revenue dollar as net income compared to RXO's -1.7%. On growth, CHRW holds the edge at -0.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | RXORXO, Inc. | CHRWC.H. Robinson Wor… |
|---|---|---|
| RevenueTrailing 12 months | $5.7B | $16.2B |
| EBITDAEarnings before interest/tax | $79M | $896M |
| Net IncomeAfter-tax profit | -$100M | $599M |
| Free Cash FlowCash after capex | -$8M | $858M |
| Gross MarginGross profit ÷ Revenue | +17.2% | +8.3% |
| Operating MarginEBIT ÷ Revenue | -0.6% | +4.9% |
| Net MarginNet income ÷ Revenue | -1.7% | +3.7% |
| FCF MarginFCF ÷ Revenue | -0.1% | +5.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -11.9% | -0.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -80.0% | +9.9% |
CHRW leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
RXO leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, CHRW's 23.9x EV/EBITDA is more attractive than RXO's 37.4x.
| Metric | RXORXO, Inc. | CHRWC.H. Robinson Wor… |
|---|---|---|
| Market CapShares × price | $3.2B | $20.0B |
| Enterprise ValueMkt cap + debt − cash | $4.1B | $21.5B |
| Trailing P/EPrice ÷ TTM EPS | -33.25x | 34.90x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 27.41x |
| PEG RatioP/E ÷ EPS growth rate | — | 6.51x |
| EV / EBITDAEnterprise value multiple | 37.38x | 23.91x |
| Price / SalesMarket cap ÷ Revenue | 0.56x | 1.23x |
| Price / BookPrice ÷ Book value/share | 2.14x | 11.10x |
| Price / FCFMarket cap ÷ FCF | — | 22.35x |
RXO leads this category, winning 3 of 4 comparable metrics.
Profitability & Efficiency
CHRW leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CHRW delivers a 33.3% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-6 for RXO. RXO carries lower financial leverage with a 0.56x debt-to-equity ratio, signaling a more conservative balance sheet compared to CHRW's 0.88x. On the Piotroski fundamental quality scale (0–9), CHRW scores 7/9 vs RXO's 6/9, reflecting strong financial health.
| Metric | RXORXO, Inc. | CHRWC.H. Robinson Wor… |
|---|---|---|
| ROE (TTM)Return on equity | -6.4% | +33.3% |
| ROA (TTM)Return on assets | -3.1% | +11.5% |
| ROICReturn on invested capital | -0.2% | +18.0% |
| ROCEReturn on capital employed | -0.3% | +25.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.56x | 0.88x |
| Net DebtTotal debt minus cash | $843M | $1.5B |
| Cash & Equiv.Liquid assets | $18M | $161M |
| Total DebtShort + long-term debt | $861M | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | -2.63x | 6.27x |
CHRW leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
CHRW leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CHRW five years ago would be worth $18,408 today (with dividends reinvested), compared to $9,343 for RXO. Over the past 12 months, CHRW leads with a +93.7% total return vs RXO's +42.6%. The 3-year compound annual growth rate (CAGR) favors CHRW at 19.6% vs RXO's 0.5% — a key indicator of consistent wealth creation.
| Metric | RXORXO, Inc. | CHRWC.H. Robinson Wor… |
|---|---|---|
| YTD ReturnYear-to-date | +52.8% | +3.4% |
| 1-Year ReturnPast 12 months | +42.6% | +93.7% |
| 3-Year ReturnCumulative with dividends | +1.4% | +70.9% |
| 5-Year ReturnCumulative with dividends | -6.6% | +84.1% |
| 10-Year ReturnCumulative with dividends | -6.6% | +160.9% |
| CAGR (3Y)Annualised 3-year return | +0.5% | +19.6% |
CHRW leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — RXO and CHRW each lead in 1 of 2 comparable metrics.
Risk & Volatility
CHRW is the less volatile stock with a 0.95 beta — it tends to amplify market swings less than RXO's 2.74 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RXO currently trades 96.3% from its 52-week high vs CHRW's 82.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | RXORXO, Inc. | CHRWC.H. Robinson Wor… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.74x | 0.95x |
| 52-Week HighHighest price in past year | $20.38 | $203.34 |
| 52-Week LowLowest price in past year | $10.43 | $86.58 |
| % of 52W HighCurrent price vs 52-week peak | +96.3% | +82.9% |
| RSI (14)Momentum oscillator 0–100 | 54.3 | 41.3 |
| Avg Volume (50D)Average daily shares traded | 1.8M | 1.7M |
Evenly matched — RXO and CHRW each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates RXO as "Hold" and CHRW as "Hold". Consensus price targets imply 11.1% upside for CHRW (target: $187) vs -18.5% for RXO (target: $16). CHRW is the only dividend payer here at 1.47% yield — a key consideration for income-focused portfolios.
| Metric | RXORXO, Inc. | CHRWC.H. Robinson Wor… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $16.00 | $187.38 |
| # AnalystsCovering analysts | 20 | 46 |
| Dividend YieldAnnual dividend ÷ price | — | +1.5% |
| Dividend StreakConsecutive years of raises | — | 5 |
| Dividend / ShareAnnual DPS | — | $2.48 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | +1.8% |
Insufficient data to determine a leader in this category.
Key Takeaway
CHRW leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). RXO leads in 1 (Valuation Metrics). 1 tied.
Best OverallC.H. Robinson Worldwide, In… (CHRW)Leads 3 of 6 categories
Loading custom metrics...
RXO vs CHRW: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is RXO or CHRW a better buy right now?
For growth investors, RXO, Inc.
(RXO) is the stronger pick with 26. 2% revenue growth year-over-year, versus -8. 4% for C. H. Robinson Worldwide, Inc. (CHRW). C. H. Robinson Worldwide, Inc. (CHRW) offers the better valuation at 34. 9x trailing P/E (27. 4x forward), making it the more compelling value choice. Analysts rate RXO, Inc. (RXO) a "Hold" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — RXO or CHRW?
Over the past 5 years, C.
H. Robinson Worldwide, Inc. (CHRW) delivered a total return of +84. 1%, compared to -6. 6% for RXO, Inc. (RXO). Over 10 years, the gap is even starker: CHRW returned +160. 9% versus RXO's -6. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — RXO or CHRW?
By beta (market sensitivity over 5 years), C.
H. Robinson Worldwide, Inc. (CHRW) is the lower-risk stock at 0. 95β versus RXO, Inc. 's 2. 74β — meaning RXO is approximately 188% more volatile than CHRW relative to the S&P 500. On balance sheet safety, RXO, Inc. (RXO) carries a lower debt/equity ratio of 56% versus 88% for C. H. Robinson Worldwide, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — RXO or CHRW?
By revenue growth (latest reported year), RXO, Inc.
(RXO) is pulling ahead at 26. 2% versus -8. 4% for C. H. Robinson Worldwide, Inc. (CHRW). On earnings-per-share growth, the picture is similar: RXO, Inc. grew EPS 72. 8% year-over-year, compared to 25. 1% for C. H. Robinson Worldwide, Inc.. Over a 3-year CAGR, RXO leads at 6. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — RXO or CHRW?
C.
H. Robinson Worldwide, Inc. (CHRW) is the more profitable company, earning 3. 6% net margin versus -1. 7% for RXO, Inc. — meaning it keeps 3. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CHRW leads at 4. 9% versus -0. 1% for RXO. At the gross margin level — before operating expenses — RXO leads at 17. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is RXO or CHRW more undervalued right now?
Analyst consensus price targets imply the most upside for CHRW: 11.
1% to $187. 38.
07Which pays a better dividend — RXO or CHRW?
In this comparison, CHRW (1.
5% yield) pays a dividend. RXO does not pay a meaningful dividend and should not be held primarily for income.
08Is RXO or CHRW better for a retirement portfolio?
For long-horizon retirement investors, C.
H. Robinson Worldwide, Inc. (CHRW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 95), 1. 5% yield, +160. 9% 10Y return). RXO, Inc. (RXO) carries a higher beta of 2. 74 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CHRW: +160. 9%, RXO: -6. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between RXO and CHRW?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: RXO is a small-cap high-growth stock; CHRW is a mid-cap quality compounder stock. CHRW pays a dividend while RXO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(RXO: -11.9% · CHRW: -0.8%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.